health-life-recalls-ez-breathe-atomizers-on-behalf-of-nephron-pharmaceuticals

Taiwan firm recalls Breathe Atomizers

  • Taiwan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Taiwan-based Health & Life initiated a nationwide recall of 242,892 EZ Breathe Atomizers (Model #EZ-100) after becoming aware of an increase in the number... Read more

dr-russell-j-howard-the-new-non-executive-director-of-prima-biomed

Russell Howard to join Prima BioMed board

  • Australia
  • |
  • Influencers
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Prima BioMed has appointed Dr Russell J Howard as a non-executive director with immediate effect. Dr Howard brings a strong scientific background and... Read more

china-botanic-pharma-delisted-from-new-york-stock-exchange-for-noncompliance

NYSE delists China Botanic Pharma

  • China
  • |
  • Company Results
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: China Botanic Pharmaceutical received a notice from the NYSE due to its noncompliance with the plan that was previously submitted by the company on February... Read more

frost-sullivan-eu-radiology-market-to-reach-usd336-mn-in-2012

F&S: EU radiology market reached $336 mn in 2012

  • Europe
  • |
  • Analysis
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Frost & Sullivan's 'Market Trends in Europe Interventional Radiology and Cardiology', finds that the market earned approximately $336.7 million in 2012... Read more

australian-cellmid-acquires-japanese-advangen

Australian Cellmid acquires Japanese Advangen

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australia-based Cellmid plans to acquire Japanese firm Advangen that owns the FGF-5 inhibitor hair growth technology. Cellmid markets évolis hair product... Read more

oncolog-was-unable-to-sell-its-assets-since-autumn-of-2012-and-has-ended-up-filing-for-bankruptcy

European cancer firm files for bankruptcy

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Since the autumn of 2012, the board of ONCOlog has worked to find buyers for the sale of the entire company or its assets. However, these efforts have... Read more

even-those-non-diabetic-individuals-who-have-high-blood-sugar-are-prone-to-alzheimer-s

High blood sugar causes Alzheimer’s in non-diabetics

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A new study by the University of Arizona (UA), US, highlighted that elevated blood sugar levels are linked to risk for developing Alzheimer's disease.... Read more

bayer-healthcare-stops-phase-ii-trial-of-haemophilia-a-and-b-drug-bay-86-6150-after-detecting-neutralizing-antibody-led

Bayer stops haemophilia trial amidst drug safety concern...

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Bayer HealthCare has stopped its phase II/III study testing its experimental treatment BAY 86-6150 on certain haemophilia A and B patients due to safety... Read more

good-news-for-sleep-apnea-patients-fisher-paykel-launches-its-next-generation-flow-generator-range-f-p-icon

F&P ICON+ flow generator to treat sleep apnea better

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Fisher & Paykel Healthcare has introduced F&P ICON+, the next generation of its flow generator range for use in the treatment of obstructive sleep apnea... Read more

good-news-for-bird-flu-patients-a-new-dna-sequencing-technique-developed-by-taiwan-s-national-chiao-tung-university-nctu-can-sequence-a-viral-genome-in-just-one-hour-instead-of-one-day

Ultra-fast DNA sequencer to detect bird flu

  • Taiwan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A team of scientists from the National Chiao Tung University (NCTU), Hsinchu City, Taiwan, developed a rapid, precise and economical technique for single-molecule... Read more

pharmabcine-uses-avacta-analytical-optim-1000-microvolume-protein-analysis-instrument-to-complete-formulation-and-stability-studies

PharmAbcine uses Avacta instrument for R&D

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Scientists at Korean biotech company PharmAbcine are completing formulation and stability studies based on Optim 1000 microvolume protein analysis and... Read more

patrys-cancer-drug-gives-hope-to-patients

Patrys cancer drug gives hope to patients

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Patrys, a clinical stage biopharmaceutical company, has confirmed anti-cancer properties of PAT-SM6 and has demonstrated the mechanism by which it occurs... Read more

chinese-and-hong-kong-researchers-develop-map-of-avian-influenza-h7n9-comprising-of-bird-migration-patterns-and-estimations-of-poultry-production-and-consumption

Chinese, Hong Kong scientists map H7N9 risk infection

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A map of avian influenza (H7N9), comprising of bird migration patterns and estimations of poultry production and consumption, which can be used to determine... Read more

the-acquisition-combines-inviragen-s-expertise-in-viral-vaccine-r-d-and-takeda-s-resources-product-development-expertise-and-global-reach

Novartis: Lucentis reduces AMD blindness by 50%

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Novartis revealed new clinical data associated with the eye drug Lucentis (ranibizumab) admist a total of 209 abstracts from other organizations at the... Read more

the-acquisition-combines-inviragen-s-expertise-in-viral-vaccine-r-d-and-takeda-s-resources-product-development-expertise-and-global-reach

Takeda to acquire Inviragen for $250 mn

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Japanese company, Takeda Pharmaceutical is looking to acquire Inviragen for an upfront payment of $35 million, and future payments of up to $215 million,... Read more

Special Features

Survey Box

Chinese Bird Flu H7N9

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X